Inhibition of inducible nitric oxide synthase ameliorates myocardial ischemia/reperfusion injury - Induced acute renal injury

Transplantation Proceedings

Volumn 46, Issue 4, 2014, Pages 1123-1126

  Chen, T H ^a   Liao, F T ^b   Yang, Y C ^b   Wang, J J ^b  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; METHYLGUANIDINE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) NITROARGININE METHYL ESTER; NITROGEN; AMIDINE; BENZYLAMINE DERIVATIVE; BIOLOGICAL MARKER; ENZYME INHIBITOR; N-(3-(AMINOMETHYL)BENZYL)ACETAMIDINE; NOS2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORONARY REPERFUSION; DRUG EFFICACY; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; KIDNEY INJURY; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD PRESSURE; CELL PROTECTION; COMPARATIVE STUDY; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME;

ACUTE KIDNEY INJURY; AMIDINES; ANIMALS; BENZYLAMINES; BIOLOGICAL MARKERS; BLOOD PRESSURE; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; INJECTIONS, INTRAPERITONEAL; KIDNEY; MALE; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84900333785     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.12.018     Document Type: Conference Paper

References (9)

1. H. Parlakpinar, M.K. Ozer, and E. Cicek et al. Renal damage in rats induced by myocardial ischemia/reperfusion: role of nitric oxide Int J Urol 13 10 2006 1327 1332
2. A.A. Kramer, G. Postler, and K.F. Salhab et al. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability Kidney Int 55 6 1999 2362 2367
3. H. Yamasowa, S. Shimizu, and T. Inoue et al. Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning J Pharmacol Exp Ther 312 1 2005 153 159
4. S. Bayrak, B. Pehlivanoglu, and Z.D. Balkanci et al. The effects of transient systemic hypotension on renal oxidative status, morphology and plasma nitric oxide levels in pregnant rats J Matern Fetal Neonatal Med 22 6 2009 528 536
5. K. Jarvinen, K. Vuolteenaho, and R. Nieminen et al. Selective iNOS inhibitor 1400W enhances anti-catabolic IL-10 and reduces destructive MMP-10 in OA cartilage. Survey of the effects of 1400W on inflammatory mediators produced by OA cartilage as detected by protein antibody array Clin Exp Rheumatol 26 2 2008 275 282
6. A.M. Jones, D.P. Wilkerson, and I.T. Campbell Nitric oxide synthase inhibition with L-NAME reduces maximal oxygen uptake but not gas exchange threshold during incremental cycle exercise in man J Physiol 560 Pt 1 2004 329 338
7. J.A. Komisarof, G.M. Gilkey, and D.M. Peters et al. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON) Crit Care Med 35 2 2007 435 441
8. T.B. Andrasi, H. Bielik, and A. Blazovics et al. Mesenteric vascular dysfunction after cardiopulmonary bypass with cardiac arrest is aggravated by coexistent heart failure Shock 23 4 2005 324 329
9. N. Ersoz, A. Guven, and T. Cayci et al. Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS Ren Fail 31 8 2009 704 710